Regulation of c-fos transcription by chemopreventive isoflavonoids and lignans in MDA-MB-468 breast cancer cells

European Journal of Cancer

Volumn 34, Issue 9, 1998, Pages 1425-1431

  Schultze Mosgau, M H ^a   Dale, I L ^b   Gant, T W ^a   Chipman, J K ^c   Kerr, D J ^c   Gescher, A ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b Cantab Pharmaceuticals Ltd   (United Kingdom)

^c NONE

Author keywords

c fos; Chemoprevention; Equol; Genistein; Lignans; Nordihydrognaiaretic acid; Transcription

Indexed keywords

ENTERODIOL; ENTEROLACTONE; EQUOL; GENISTEIN; MANDELIC ACID; NORDIHYDROGUAIARETIC ACID;

ARTICLE; BREAST CANCER; CANCER PREVENTION; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; ONCOGENE C FOS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

BREAST NEOPLASMS; CARCINOGENS; FEMALE; GENES, FOS; HUMANS; ISOFLAVONES; LIGNANS; NORDIHYDROGUAIARETIC ACID; PROTEIN KINASE C; PROTEIN-TYROSINE KINASES; RNA, MESSENGER; RNA, NEOPLASM; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0032145314     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(98)00223-8     Document Type: Article

References (34)

1. 1. Setchell KDR, Boriello SP, Axelson M. Nonsteroidal estrogens of dietary origin: possible role in hormone-dependent disease. Am J Clin Nutr 1984, 40, 569-578.
2. 2. Barnes S. Effect of genistein on in vitro and in vivo models of cancer. J Nutr 1995, 125, 777S-783S.
3. 3. Adlercreutz H, Honjo H, Fotsis T, Hämäläinen E, Hasegavwa T, Okada H. Urinary excretion of lignans and isoflavonoid phytoestrogens in Japanese diet. Am J Clin Nutr 1991, 54, 1093-1100.
4. 4. Martin PM, Horwitz KB, Ryan DS, McGuire WL. Phytoestrogen interaction with estrogen receptor in human breast cancer cells. Endocrinol 1978, 103, 1860-1867.
5. 5. Welshons WV, Murphy CS, Koch R, Calaf GD, Jordan VC. Stimulation of breast cancer cells in vitro by the environmental estrogen enterolactone and the phytoestrogen equol. Breast Cancer Res Treat 1987, 10, 165-175.
6. 6. Wei H, Bowen R, Cai Q, Barnes S, Wang Y. Antioxidant and antipromotional effects of the soybean isoflavone genistein. Proc Soc Exp Biol Med 1995, 208, 124-130.
7. 7. Yamashita Y, Kawada S, Nakano H. Induction of mammalian topoisomerase II-dependent DNA cleavage by nonintercalative flavonoids, genistein and orobol. Biochem Pharmacol 1990, 39, 737-744.
8. 8. Akiyama T, Ishida J, Nakagawa S, et al. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 1987, 262, 5592-5595.
9. 9. Yanagihara K, Ito A, Toge T, Numoto M. Antiproliferative effects of isoflavones on human cancer cell lines established from the gastrointestinal tract. Cancer Res 1993, 53, 5815-5821.
10. 10. Hirano T, Gotoh M, Oka K. Natural flavonoids and lignans are potent cytostatic agents against human leukemic HL-60 cells. Life Sci 1994, 55, 1061-1069.
11. 11. Coward L, Barnes NC, Setchell KDR, Barnes S. The antitumor isoflavones genistein and daidzein in soybean foods of American and Asian diets. J Agric Food Chem 1994, 42, 2466-2474.
12. 12. Adlercreutz H. Does fiber-rich food containing animal lignan precursors protect against both colon and breast cancer? An extension of the 'Fiber hypothesis'. Gastroenterology 1984, 86, 761-764.
13. 13. McCormick DL, Spicer AM. Nordihydroguaiaretic acid suppression of rat mammary carcinogenesis induced by N-methyl-N-nitrosourea. Cancer Lett 1987, 34, 139-146.
14. 14. Katz M, Saibil F. Herbal hepatitis: subacute hepatic necrosis secondary to chaparral leaf. J Clin Gastroenterol 1990, 12, 203-206.
15. 15. Markarevich BM, Gregory RR, Alejandro MA, Clark JH, Johnson GA, Middleditch BS. Methyl p-hydroxyphenyllactate. An inhibitor of cell growth and proliferation and an endogenous ligand for nuclear type-II binding sites. J Biol Chem 1988, 263, 7203-7210.
16. 16. Peterson G, Barnes S. Genistein inhibition of the growth of human breast cancer cells: independence from estrogen receptors and the multi-drug resistance gene. Biochem Biophys Res Commun 1991, 179, 661-667.
17. 17. Adlercreutz H. Western diet and Western diseases: some hormonal and biochemical mechanisms and associations. Scand J Clin Lab Invest 1990, 50(Suppl. 201), 3-23.
18. 18. Thorn D, Powell AJ, Lloyd CW, Rees DA. Rapid isolation of plasma membranes in high yield from cultured fibroblasts. Biochem J 1977, 168, 187-194.
19. 19. Dale IL, Bradshaw TD, Gescher A, Pettit GR. Effects of bryostatins 1 and 2 and 12-O-tetradecanoylphorbol-13-acetate on protein kinase C activity in A549 human lung carcinoma cells. Cancer Res 1989, 49, 3242-3245.
20. 20. Greenberg ME, Ziff EB. Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene. Nature 1984, 311, 433-437.
21. 21. Wei H, Barnes S, Wang Y. Inhibitory effect of genistein on a tumor promotor-induced c-fos and c-jun expression in mouse skin. Oncol Report 1996, 3, 125-128.
22. 22. Toullec D, Pianetti P, Coste H, et al. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem 1991, 266, 15771-15781.
23. 23. Onoda T, Inuma H, Sasaki Y, et al. Isolation of a novel tyrosine kinase inhibitor, Lavendustin-A, from streptomyces-griseola-vendus. J Nat Prod 1989, 52, 1252-1257.
24. 24. Buchdunger E, Trinks U, Mett H, et al. 4,5-Dianilinophtalimide: a protein-tyrosine kinase inhibitor with selectivity for the epidermal growth factor receptor signal transduction pathway and potent in vivo antitumor activity. Proc Natl Acad Sci USA 1994, 91, 2334-2338.
25. 25. Earashi M, Noguchi M, Kinoshita K, Tanaka M. Effects of eicosanoid synthesis inhibitors on the in vitro growth and prostaglandin E and leukotriene B secretion of a human breast cancer cell line. Oncology 1995, 52, 150-155.
26. 26. Higgs GA, Vane JR. Inhibition of cyclooxygenase and lipoxygenase. Br Med Bull 1983, 39, 265-270.
27. 27. Capdevila J, Geil L, Orellana M, et al. Inhibitors of cytochrome P-450-dependent arachidonic-acid metabolism. Arch Biochem Biophys 1988, 261, 257-263.
28. 28. Andrejauskas-Buchdunger E, Regenass U. Differential inhibition of the epidermal growth factor-, platelet-derived growth factor-, and protein kinase C-mediated signal transduction pathways by the staurosporine derivative CGP 41251. Cancer Res 1992, 52, 5353-5358.
29. 29. Peterson G, Barnes S. Genistein inhibits both estrogen and growth factor-stimulated proliferation of human breast cancer cells. Cell Growth & Diff 1996, 7, 1345-1351.
30. 30. Marquardt B, Frith D, Stabel S. Signalling from TPA to MAP kinase requires protein kinase C, raf and MEK: reconstitution of the signalling pathway in vitro. Oncogene 1994, 9, 3213-3218.
31. 31. Domin J, Higgins T, Rozengurt E. Preferential inhibition of platelet-derived growth factor-stimulated DNA synthesis and protein tyrosine phosphorylation by nordihydroguaiaretic acid. J Biol Chem 1994, 269, 8260-8267.
32. 32. Keogh BP, Treisni M, Cristofalo VC, Allen RG. Effects of cellular aging on the induction of c-fos by antioxidant treatments. Mechanisms Aging Development 1996, 86, 151-160.
33. 33. Xu X, Wang HJ, Murphy PA, Cook L, Hendrich S. Daidzine is a more bioavailable soymilk isoflavone than is genistein in adult women. J Nutr 1994, 124, 825-832.
34. 34. Barnes S, Peterson TG, Coward L. Rationale for the use of genistein-containing soy matrices in chemoprevention trials for breast and prostate cancer. J Cell Biochem 1995, 22(Suppl.), 181-187.